Lindsey J Noble1, Venkat B Meruva2, Seth A Hays3, Robert L Rennaker4, Michael P Kilgard1, Christa K McIntyre5. 1. The University of Texas at Dallas, School of Behavior and Brain Sciences, 800 West Campbell Road, Richardson, TX, 75080-3021, United States; The University of Texas at Dallas, Texas Biomedical Device Center, 800 West Campbell Road, Richardson, TX, 75080-3021, United States. 2. The University of Texas at Dallas, School of Behavior and Brain Sciences, 800 West Campbell Road, Richardson, TX, 75080-3021, United States. 3. The University of Texas at Dallas, Texas Biomedical Device Center, 800 West Campbell Road, Richardson, TX, 75080-3021, United States; The University of Texas at Dallas, Erik Jonsson School of Engineering and Computer Science, 800 West Campbell Road, Richardson, TX, 75080-3021, United States. 4. The University of Texas at Dallas, School of Behavior and Brain Sciences, 800 West Campbell Road, Richardson, TX, 75080-3021, United States; The University of Texas at Dallas, Texas Biomedical Device Center, 800 West Campbell Road, Richardson, TX, 75080-3021, United States; The University of Texas at Dallas, Erik Jonsson School of Engineering and Computer Science, 800 West Campbell Road, Richardson, TX, 75080-3021, United States. 5. The University of Texas at Dallas, School of Behavior and Brain Sciences, 800 West Campbell Road, Richardson, TX, 75080-3021, United States; The University of Texas at Dallas, Texas Biomedical Device Center, 800 West Campbell Road, Richardson, TX, 75080-3021, United States. Electronic address: christa.mcintyre@utdallas.edu.
Abstract
BACKGROUND: Exposure-based therapies are used to treat a variety of trauma- and anxiety-related disorders by generating successful extinction following cue exposure during treatment. The development of adjuvant strategies that accelerate extinction learning, improve tolerability, and increase efficiency of treatment could increase the efficacy of exposure-based therapies. Vagus nerve stimulation (VNS) paired with exposure can enhance fear extinction, in rat models of psychiatric disorders, and chronic administration of VNS reduces anxiety in rats and humans. OBJECTIVE: We tested whether VNS, like other cognitive enhancers, could produce generalization of extinction for stimuli that are not presented during the extinction sessions, but are associated with the fear event. METHODS: Male Sprague Dawley rats underwent auditory fear conditioning with two easily discriminable auditory stimuli. Following fear conditioning, extinction training consisted of exposure to only one of the conditioned sounds. Half of the rats received VNS and half received sham stimulation during with sound presentations. VNS effects on anxiety were examined in a separate study where VNS was administered prior to testing on the elevated plus maze. RESULTS: Sham stimulated rats given 20 presentations of a conditioned stimulus (CS) during the extinction session showed performance that was matched to VNS-treated rats given only 4 presentations of the CS. Despite comparable levels of freezing to the presented CS, only the VNS-treated rats showed a significant decrease in freezing to the CS that was not presented. VNS-induced generalization of extinction was observed only when the two sounds were paired with footshock within the same fear conditioning session; VNS did not promote generalization of extinction when the two sounds were conditioned on different days or in different contexts. On the anxiety test, VNS administration significantly increased time spent in the open arms of the elevated plus maze. CONCLUSION: These results provide evidence that VNS can promote generalization of extinction to other stimuli associated with a specific fear experience. Furthermore, non-contingent VNS appears to reduce anxiety. The ability to generalize extinction and reduce anxiety makes VNS a potential candidate for use as an adjunctive strategy to improve the efficacy and tolerability of exposure-based therapies.
BACKGROUND: Exposure-based therapies are used to treat a variety of trauma- and anxiety-related disorders by generating successful extinction following cue exposure during treatment. The development of adjuvant strategies that accelerate extinction learning, improve tolerability, and increase efficiency of treatment could increase the efficacy of exposure-based therapies. Vagus nerve stimulation (VNS) paired with exposure can enhance fear extinction, in rat models of psychiatric disorders, and chronic administration of VNS reduces anxiety in rats and humans. OBJECTIVE: We tested whether VNS, like other cognitive enhancers, could produce generalization of extinction for stimuli that are not presented during the extinction sessions, but are associated with the fear event. METHODS: Male Sprague Dawley rats underwent auditory fear conditioning with two easily discriminable auditory stimuli. Following fear conditioning, extinction training consisted of exposure to only one of the conditioned sounds. Half of the rats received VNS and half received sham stimulation during with sound presentations. VNS effects on anxiety were examined in a separate study where VNS was administered prior to testing on the elevated plus maze. RESULTS: Sham stimulated rats given 20 presentations of a conditioned stimulus (CS) during the extinction session showed performance that was matched to VNS-treated rats given only 4 presentations of the CS. Despite comparable levels of freezing to the presented CS, only the VNS-treated rats showed a significant decrease in freezing to the CS that was not presented. VNS-induced generalization of extinction was observed only when the two sounds were paired with footshock within the same fear conditioning session; VNS did not promote generalization of extinction when the two sounds were conditioned on different days or in different contexts. On the anxiety test, VNS administration significantly increased time spent in the open arms of the elevated plus maze. CONCLUSION: These results provide evidence that VNS can promote generalization of extinction to other stimuli associated with a specific fear experience. Furthermore, non-contingent VNS appears to reduce anxiety. The ability to generalize extinction and reduce anxiety makes VNS a potential candidate for use as an adjunctive strategy to improve the efficacy and tolerability of exposure-based therapies.
Authors: M S George; H A Sackeim; A J Rush; L B Marangell; Z Nahas; M M Husain; S Lisanby; T Burt; J Goldman; J C Ballenger Journal: Biol Psychiatry Date: 2000-02-15 Impact factor: 13.382
Authors: Daniel R Hulsey; Jonathan R Riley; Kristofer W Loerwald; Robert L Rennaker; Michael P Kilgard; Seth A Hays Journal: Exp Neurol Date: 2016-12-14 Impact factor: 5.330
Authors: Crystal T Engineer; Claudia A Perez; Ryan S Carraway; Kevin Q Chang; Jarod L Roland; Andrew M Sloan; Michael P Kilgard Journal: PLoS One Date: 2013-10-16 Impact factor: 3.240
Authors: Michael J Darrow; Tabarak M Mian; Miranda Torres; Zainab Haider; Tanya Danaphongse; Armin Seyedahmadi; Robert L Rennaker; Seth A Hays; Michael P Kilgard Journal: Behav Brain Res Date: 2020-09-21 Impact factor: 3.332
Authors: Matthew T Wittbrodt; Nil Z Gurel; Jonathon A Nye; Md Mobashir H Shandhi; Asim H Gazi; Amit J Shah; Bradley D Pearce; Nancy Murrah; Yi-An Ko; Lucy H Shallenberger; Viola Vaccarino; Omer T Inan; J Douglas Bremner Journal: Psychosom Med Date: 2021 Nov-Dec 01 Impact factor: 4.312
Authors: Jacek Kolacz; Lourdes P Dale; Evan J Nix; Olivia K Roath; Gregory F Lewis; Stephen W Porges Journal: Front Psychiatry Date: 2020-10-27 Impact factor: 4.157
Authors: J Douglas Bremner; Nil Z Gurel; Yunshen Jiao; Matthew T Wittbrodt; Oleksiy M Levantsevych; Minxuan Huang; Hewon Jung; MdMobashir H Shandhi; Joy Beckwith; Isaias Herring; Mark H Rapaport; Nancy Murrah; Emily Driggers; Yi-An Ko; MhmtJamil L Alkhalaf; Majd Soudan; Jiawei Song; Benson S Ku; Lucy Shallenberger; Allison N Hankus; Jonathon A Nye; Jeanie Park; Viola Vaccarino; Amit J Shah; Omer T Inan; Bradley D Pearce Journal: Brain Behav Immun Health Date: 2020-09-11